Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NFYC pseudogene 2 is a processed pseudogene and does not encode a functional protein. It is related by sequence similarity to the NFYC gene, which encodes a subunit of a trimeric transcription factor (NF-Y) that binds to CCAAT motifs in gene promoters. As a pseudogene, NFYCP2 lacks the capacity to produce a functional transcript or protein and is not implicated in disease mechanisms or therapeutic targeting. Although some pseudogenes may have regulatory functions (e.g., as competing endogenous RNAs)[1][11], there is no evidence that NFYCP2 has such a function or clinical relevance. This locus is cataloged for genomic annotation but is not considered a legitimate drug target[5][7][9]. NFYCP2 is not a therapeutic target; it is a non-functional genomic element. The term “pseudogene” indicates it is not expected to play a direct role in coding for functional proteins or to be suitable for pharmacological targeting[5][7][9]. There is nothing to suggest alternative splicing, translation, or known disease association.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NFYC pseudogene 2 (NFYCP2).